2 Notable Biotech Calls

It has not been a good day for investors this Thursday.  Worries about trade, the situation in Saudi Arabia, plunging oil prices, falling …

Uniqure NV (QURE) Is Getting the Street All Fired Up on Its Gene Therapy Candidate in Hemophilia B; Oppenheimer Spotlights Efficacy/Safety Strength

Hartaj Singh believes QURE trots out an upper hand advantage with AMT-061.

Gene Therapy Attack Capital Time? QURE

UniQure (NASDAQ:QURE) is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts